Intravenous Immunoglobulin Plus Interferon- in Autoimmune Hepatitis C

Author： Malaguarnera M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.18, Iss.1, 2004-01, pp. : 63-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon- Alone versus Interferon- plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon- Treatment

By Tripi S.  

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 299-304

Adis International

Access to resources Recommend Favorite

Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders

By Larroche C.  

BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 47-55

Adis International

Access to resources Recommend Favorite

Interleukin-2 Plus Ribavirin Versus Interferon- -2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon- -2b Treatment

By Mariano Malaguarnera  

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 407-413

Adis International

Access to resources Recommend Favorite

Interferon- (IFN ) Daily Dose Versus IFN Plus Ribavirin for Treatment-Naive Chronic Hepatitis C Patients Infected by Genotype 1b

By Scotto G.  

BioDrugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 281-286

Adis International

Access to resources Recommend Favorite

Interferon Alfacon-1: A Novel Interferon for the Treatment of Chronic Hepatitis C

By Alberti A.  

BioDrugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 343-357

Adis International

Access to resources Recommend Favorite